Immune response to mutant neo-antigens

References

• Simpson AJ. The natural somatic mutation frequency and human carcinogenesis. Adv Cancer Res 1997; 71:209 - 40; http://dx.doi.org/10.1016/S0065-230X(08)60100-1; PMID: 9111867
   PubMed Web of Science ®Google Scholar
• Beckman RA, Loeb LA. Genetic instability in cancer: theory and experiment. Semin Cancer Biol 2005; 15:423 - 35; http://dx.doi.org/10.1016/j.semcancer.2005.06.007; PMID: 16043359
   PubMed Web of Science ®Google Scholar
• Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007; 446:153 - 8; http://dx.doi.org/10.1038/nature05610; PMID: 17344846
   PubMed Web of Science ®Google Scholar
• Stringer JR, Larson JS, Fischer JM, Medvedovic M, Hersh MN, Boivin GP, Stringer SL. Modeling variation in tumors in vivo.. Proc Natl Acad Sci U S A 2005; 102:2408 - 13; http://dx.doi.org/10.1073/pnas.0401340102; PMID: 15695337
   PubMed Web of Science ®Google Scholar
• Fischer JM, Stringer JR. Mutation in aging mice occurs in diverse cell types that proliferate postmutation. Aging Cell 2008; 7:667 - 80; http://dx.doi.org/10.1111/j.1474-9726.2008.00416.x; PMID: 18652575
   PubMed Web of Science ®Google Scholar
• Stratton MR, Campbell PJ, Futreal PA. The cancer genome. Nature 2009; 458:719 - 24; http://dx.doi.org/10.1038/nature07943; PMID: 19360079
   PubMed Web of Science ®Google Scholar
• Castle JC, Kreiter S, Diekmann J, Löwer M, van de Roemer N, de Graaf J, Selmi A, Diken M, Boegel S, Paret C, et al. Exploiting the mutanome for tumor vaccination. Cancer Res 2012; 72:1081 - 91; http://dx.doi.org/10.1158/0008-5472.CAN-11-3722; PMID: 22237626
   PubMed Web of Science ®Google Scholar
• Matsushita H, Vesely MD, Koboldt DC, Rickert CG, Uppaluri R, Magrini VJ, Arthur CD, White JM, Chen YS, Shea LK, et al. Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. Nature 2012; 482:400 - 4; http://dx.doi.org/10.1038/nature10755; PMID: 22318521
   PubMed Web of Science ®Google Scholar
• van der Bruggen P, Stroobant V, Vigneron N, Van den Eynde B. Peptide database: T cell-defined tumor antigens. Cancer Immun 2013; http://www.cancerimmunity.org/peptide/
   Google Scholar
• Berendt MJ, North RJ. T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med 1980; 151:69 - 80; http://dx.doi.org/10.1084/jem.151.1.69; PMID: 6444236
   PubMed Web of Science ®Google Scholar
• Engelhorn ME, Guevara-Patiño JA, Noffz G, Hooper AT, Lou O, Gold JS, Kappel BJ, Houghton AN. Autoimmunity and tumor immunity induced by immune responses to mutations in self. Nat Med 2006; 12:198 - 206; http://dx.doi.org/10.1038/nm1363; PMID: 16444264
   PubMed Web of Science ®Google Scholar
• Roopenian D, Choi EY, Brown A. The immunogenomics of minor histocompatibility antigens. Immunol Rev 2002; 190:86 - 94; http://dx.doi.org/10.1034/j.1600-065X.2002.19007.x; PMID: 12493008
   PubMed Web of Science ®Google Scholar
• Krohn PL. Review Lecture on Senescence. II. Heterochronic transplantation in the study of aging. Proceeding of the Royal Society of London. Series B, Biological Sciences 1962; 157: 128-147.
   Google Scholar
• Rabinovich GA, Gabrilovich D, Sotomayor EM. Immunosuppressive strategies that are mediated by tumor cells. Annu Rev Immunol 2007; 25:267 - 96; http://dx.doi.org/10.1146/annurev.immunol.25.022106.141609; PMID: 17134371
   PubMed Web of Science ®Google Scholar
• Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252 - 64; http://dx.doi.org/10.1038/nrc3239; PMID: 22437870
   PubMed Web of Science ®Google Scholar
• Ochsenbein AF, Klenerman P, Karrer U, Ludewig B, Pericin M, Hengartner H, Zinkernagel RM. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci U S A 1999; 96:2233 - 8; http://dx.doi.org/10.1073/pnas.96.5.2233; PMID: 10051624
   PubMed Web of Science ®Google Scholar
• Ochsenbein AF. Immunological ignorance of solid tumors. Springer Semin Immunopathol 2005; 27:19 - 35; http://dx.doi.org/10.1007/s00281-004-0192-0; PMID: 15965711
   PubMed Web of Science ®Google Scholar
• Wilcox RA, Flies DB, Zhu G, Johnson AJ, Tamada K, Chapoval AI, Strome SE, Pease LR, Chen L. Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors. J Clin Invest 2002; 109:651 - 9; PMID: 11877473
   PubMed Web of Science ®Google Scholar
• Srivastava PK. Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses. Annu Rev Immunol 2002; 20:395 - 425; http://dx.doi.org/10.1146/annurev.immunol.20.100301.064801; PMID: 11861608
   PubMed Web of Science ®Google Scholar
• Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev 2007; 220:251 - 69; http://dx.doi.org/10.1111/j.1600-065X.2007.00572.x; PMID: 17979852
   PubMed Web of Science ®Google Scholar
• Harris HE, Andersson U, Pisetsky DS. HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. Nat Rev Rheumatol 2012; 8:195 - 202; http://dx.doi.org/10.1038/nrrheum.2011.222; PMID: 22293756
   PubMed Web of Science ®Google Scholar
• Vriens J, Appendino G, Nilius B. Pharmacology of vanilloid transient receptor potential cation channels. Mol Pharmacol 2009; 75:1262 - 79; http://dx.doi.org/10.1124/mol.109.055624; PMID: 19297520
   PubMed Web of Science ®Google Scholar
• Basu S, Srivastava PK. Immunological role of neuronal receptor vanilloid receptor 1 expressed on dendritic cells. Proc Natl Acad Sci U S A 2005; 102:5120 - 5; http://dx.doi.org/10.1073/pnas.0407780102; PMID: 15793000
   PubMed Web of Science ®Google Scholar
• Fedarko NS. (2010) Geriatrics Review Syllabus, 7th Edition (eds JT Pacala and GM Sullivan). Chapter 2: Biology, pp 9-19.
   Google Scholar
• Kirkwood TBL. Understanding the odd science of aging. Cell 2005; 120:437 - 47; http://dx.doi.org/10.1016/j.cell.2005.01.027; PMID: 15734677
   PubMed Web of Science ®Google Scholar
• Baker DJ, Wijshake T, Tchkonia T, LeBrasseur NK, Childs BG, van de Sluis B, Kirkland JL, van Deursen JM. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 2011; 479:232 - 6; http://dx.doi.org/10.1038/nature10600; PMID: 22048312
   PubMed Web of Science ®Google Scholar
• Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Curr Biol 1999; 9:939 - 45; http://dx.doi.org/10.1016/S0960-9822(99)80420-5; PMID: 10508581
   PubMed Web of Science ®Google Scholar
• Norris PG, Limb GA, Hamblin AS, Lehmann AR, Arlett CF, Cole J, Waugh AP, Hawk JL. Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne’s syndrome, and trichothiodystrophy. J Invest Dermatol 1990; 94:94 - 100; http://dx.doi.org/10.1111/1523-1747.ep12873952; PMID: 2295840
   PubMed Web of Science ®Google Scholar
• Garinis GA, van der Horst GT, Vijg J, Hoeijmakers JH. DNA damage and ageing: new-age ideas for an age-old problem. Nat Cell Biol 2008; 10:1241 - 7; http://dx.doi.org/10.1038/ncb1108-1241; PMID: 18978832
   PubMed Web of Science ®Google Scholar
• Dingli D, Traulsen A, Michor F. (A)symmetric stem cell replication and cancer. PLoS Comput Biol 2007; 3:e53; http://dx.doi.org/10.1371/journal.pcbi.0030053; PMID: 17367205
   PubMedGoogle Scholar